What is a stock summary page? Click here for an overview.
Business Description
Shandong Wohua Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2834
ISIN : CNE000001QB8
Share Class Description:
SZSE:002107: Class ACompare
Compare
Traded in other countries / regions
002107.China IPO Date
2007-01-24Description
Shandong Wohua Pharmaceutical Co Ltd is a China-based company specializing in the field of cardio-cerebral vascular medicine. The company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Naoxueshu oral liquid, promoting blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus, and Yuandu granules for the treatment of influenza, among others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3763.91 | |||||
| Equity-to-Asset | 0.69 | |||||
| Interest Coverage | 1056.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7 | |||||
| Beneish M-Score | -3.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.9 | |||||
| 3-Year EBITDA Growth Rate | -30.1 | |||||
| 3-Year EPS without NRI Growth Rate | -29.9 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | -0.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.3 | |||||
| 9-Day RSI | 38 | |||||
| 14-Day RSI | 41.48 | |||||
| 3-1 Month Momentum % | -6.49 | |||||
| 6-1 Month Momentum % | -2.83 | |||||
| 12-1 Month Momentum % | -7.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | |||||
| Quick Ratio | 1.65 | |||||
| Cash Ratio | 1.28 | |||||
| Days Inventory | 226.78 | |||||
| Days Sales Outstanding | 33.69 | |||||
| Days Payable | 91.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.64 | |||||
| Dividend Payout Ratio | 6.1 | |||||
| Forward Dividend Yield % | 5.64 | |||||
| 5-Year Yield-on-Cost % | 5.14 | |||||
| Shareholder Yield % | 5.56 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.8 | |||||
| Operating Margin % | 3.98 | |||||
| Net Margin % | 3.15 | |||||
| FCF Margin % | 13.04 | |||||
| ROE % | 3.21 | |||||
| ROA % | 2.24 | |||||
| ROIC % | 3.12 | |||||
| 3-Year ROIIC % | 57.68 | |||||
| ROC (Joel Greenblatt) % | 8.43 | |||||
| ROCE % | 3.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 121.75 | |||||
| PE Ratio without NRI | 118.78 | |||||
| Shiller PE Ratio | 27.06 | |||||
| Price-to-Owner-Earnings | 541.12 | |||||
| PEG Ratio | 47.51 | |||||
| PS Ratio | 3.65 | |||||
| PB Ratio | 4.09 | |||||
| Price-to-Tangible-Book | 4.55 | |||||
| Price-to-Free-Cash-Flow | 26.33 | |||||
| Price-to-Operating-Cash-Flow | 25.37 | |||||
| EV-to-EBIT | 71.74 | |||||
| EV-to-EBITDA | 71.74 | |||||
| EV-to-Revenue | 2.95 | |||||
| EV-to-FCF | 23.11 | |||||
| Price-to-GF-Value | 1.02 | |||||
| Price-to-Projected-FCF | 1.78 | |||||
| Price-to-Median-PS-Value | 0.86 | |||||
| Price-to-Graham-Number | 4.92 | |||||
| Price-to-Net-Current-Asset-Value | 11.88 | |||||
| Price-to-Net-Cash | 97.4 | |||||
| Earnings Yield (Greenblatt) % | 1.39 | |||||
| FCF Yield % | 3.57 | |||||
| Forward Rate of Return (Yacktman) % | -20.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Wohua Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 769.793 | ||
| EPS (TTM) (Â¥) | 0.04 | ||
| Beta | 0.73 | ||
| 3-Year Sharpe Ratio | -0.41 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 26.91 | ||
| 14-Day RSI | 41.48 | ||
| 14-Day ATR (Â¥) | 0.192948 | ||
| 20-Day SMA (Â¥) | 4.635 | ||
| 12-1 Month Momentum % | -7.84 | ||
| 52-Week Range (Â¥) | 3.46 - 5.66 | ||
| Shares Outstanding (Mil) | 577.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Wohua Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Wohua Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Wohua Pharmaceutical Co Ltd Frequently Asked Questions
What is Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107)'s stock price today?
The current price of SZSE:002107 is ¥4.87. The 52 week high of SZSE:002107 is ¥5.66 and 52 week low is ¥3.46.
When is next earnings date of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107)?
The next earnings date of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is .
Does Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is 5.64% (As of Today), Highest Dividend Payout Ratio of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) was 6.1. The lowest was 0.2. And the median was 0.57. The  Forward Dividend Yield % of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is 5.64%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers